Understanding MASH: A Global Health Challenge | Boehringer Ingelheim

The article queued up here is a pharmaceutical/liver disease piece from Boehringer Ingelheim. The "CRM" in the source is a medical abbreviation (cardiometabolic risk), not customer relationship management. There's no usable signal in it for your audience.

Rather than force a connection that would read as nonsense to any ops leader, here's what I'd suggest:

Swap in a relevant source — a CRM vendor announcement, a sales ops survey, a Salesforce/HubSpot pricing change, a study on sales team productivity — and I'll turn it into the post immediately.

If you want, I can also write a post on a related topic without a source article — common ones that land well with your audience:

- Why CRM customization projects keep failing the same way
- The real cost of workarounds your team has stopped reporting
- What mid-market ops teams actually need vs. what enterprise CRMs sell them
- Why switching platforms rarely solves the underlying problem

Drop a real source or pick a topic and I'll get it done.

Original Source

... (CRM) conditions. We're encouraging decision-makers to act on MASH as a public health threat and supporting healthcare professionals to take a more ...